Backed by Perceptive Xontogeny Venture Funds and venBio Partners, the new biotech will make genetic medicines that don’t rely on viral vectors.
More from Gwendolyn Wu
Lexeo to help launch spinout around RNA drugs for the heart
No Comments
Leave a comment Cancel